Correlation Between Inozyme Pharma and Protagonist Therapeutics
Can any of the company-specific risk be diversified away by investing in both Inozyme Pharma and Protagonist Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Inozyme Pharma and Protagonist Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Inozyme Pharma and Protagonist Therapeutics, you can compare the effects of market volatilities on Inozyme Pharma and Protagonist Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Inozyme Pharma with a short position of Protagonist Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Inozyme Pharma and Protagonist Therapeutics.
Diversification Opportunities for Inozyme Pharma and Protagonist Therapeutics
0.31 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Inozyme and Protagonist is 0.31. Overlapping area represents the amount of risk that can be diversified away by holding Inozyme Pharma and Protagonist Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Protagonist Therapeutics and Inozyme Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Inozyme Pharma are associated (or correlated) with Protagonist Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Protagonist Therapeutics has no effect on the direction of Inozyme Pharma i.e., Inozyme Pharma and Protagonist Therapeutics go up and down completely randomly.
Pair Corralation between Inozyme Pharma and Protagonist Therapeutics
Given the investment horizon of 90 days Inozyme Pharma is expected to under-perform the Protagonist Therapeutics. In addition to that, Inozyme Pharma is 1.04 times more volatile than Protagonist Therapeutics. It trades about -0.6 of its total potential returns per unit of risk. Protagonist Therapeutics is currently generating about -0.07 per unit of volatility. If you would invest 4,843 in Protagonist Therapeutics on August 30, 2024 and sell it today you would lose (348.00) from holding Protagonist Therapeutics or give up 7.19% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 95.65% |
| Values | Daily Returns |
Inozyme Pharma vs. Protagonist Therapeutics
Performance |
| Timeline |
| Inozyme Pharma |
| Protagonist Therapeutics |
Inozyme Pharma and Protagonist Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Inozyme Pharma and Protagonist Therapeutics
The main advantage of trading using opposite Inozyme Pharma and Protagonist Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Inozyme Pharma position performs unexpectedly, Protagonist Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Protagonist Therapeutics will offset losses from the drop in Protagonist Therapeutics' long position.| Inozyme Pharma vs. Day One Biopharmaceuticals | Inozyme Pharma vs. X4 Pharmaceuticals | Inozyme Pharma vs. Acumen Pharmaceuticals | Inozyme Pharma vs. Mereo BioPharma Group |
| Protagonist Therapeutics vs. Revolution Medicines | Protagonist Therapeutics vs. Akero Therapeutics | Protagonist Therapeutics vs. Avidity Biosciences | Protagonist Therapeutics vs. Stoke Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.
Other Complementary Tools
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities |